We are live on ! Find out more
DCM

DG Capital Management Portfolio holdings

AUM $326M
1-Year Est. Return 39.67%
This Fund
S&P 500
This Quarter Est. Return
+6.54%
1 Year Est. Return
+39.67%
3 Year Est. Return
+81.23%
5 Year Est. Return
+56.79%
10 Year Est. Return
AUM
$224M
AUM Growth
+$46.4M
Cap. Flow
+$30.3M
Cap. Flow %
13.5%
Top 10 Hldgs %
67.35%
Holding
41
New
11
Increased
9
Reduced
7
Closed
5

Sector Composition

Rank Sector Weight
1 Healthcare 29.45%
2 Consumer Discretionary 23.21%
3 Industrials 11.77%
4 Communication Services 6.33%
5 Financials 5.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICPT
26
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$822K 0.37%
+74,300
New +$1.04M
CYH icon
27
CALL
Community Health Systems
CYH
$382M
$440K 0.2%
+100,000
New +$426K
BUR icon
28
PUT
Burford Capital
BUR
$914M
$409K 0.18%
+33,600
New +$435K
NRACW
29
DELISTED
Northern Revival Acquisition Corporation Warrant
NRACW
$8.3K ﹤0.01%
92,734
LCAAW
30
DELISTED
L Catterton Asia Acquisition Corp Warrant
LCAAW
$6.27K ﹤0.01%
13,061
COOLW
31
DELISTED
Corner Growth Acquisition Corp. Warrant
COOLW
$5.04K ﹤0.01%
38,762
ECXWW
32
ECARX Holdings Warrants
ECXWW
$3.42K ﹤0.01%
46,113
AILEW
33
DELISTED
iLearningEngines, Inc. Warrant
AILEW
$3.31K ﹤0.01%
13,238
JWSM.WS
34
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$659 ﹤0.01%
13,189
KRE icon
35
State Street SPDR S&P Regional Banking ETF
KRE
$4.51B
-30,000
Closed -$1.32M
FMIVW
36
DELISTED
Forum Merger IV Corporation Warrant
FMIVW
-26,535
Closed -$3.32K
EOCW.WS
37
DELISTED
Elliott Opportunity II Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
EOCW.WS
-36,085
Closed -$2.42K
PNTM.WS
38
DELISTED
Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PNTM.WS
-14,376
Closed -$2.47K
ORIAW
39
DELISTED
Orion Biotech Opportunities Corp. Warrant
ORIAW
-25,870
Closed -$1.83K

Similar funds

DG Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, DG Capital Management held 41 positions worth $224M, up 26% from $178M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

DG Capital Management deployed $30.3M of net new capital in Q2 2023, opening 11 new positions and adding to 9 existing holdings. Its largest new stake was Intercept Pharmaceuticals, Inc.: 896,294 shares worth $9.91M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 32% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Summit Materials, Inc. Class A Common Stock, an estimated $8.78M trimmed.

  • DG Capital Management's largest Q2 2023 buy was Intercept Pharmaceuticals, Inc.: 896,294 shares worth $9.91M.
  • DG Capital Management added most to Community Health Systems in Q2 2023, an estimated $7.24M increase.
  • DG Capital Management's biggest Q2 2023 reduction was Summit Materials, Inc. Class A Common Stock, cutting an estimated $8.78M.
  • DG Capital Management fully exited State Street SPDR S&P Regional Banking ETF in Q2 2023, selling an estimated $1.32M.
  • DG Capital Management's ten largest holdings make up 67% of its $224M portfolio in Q2 2023.
  • DG Capital Management opened 11 new positions and closed 5 in Q2 2023.
  • DG Capital Management's portfolio value rose 26% quarter-over-quarter to $224M.

Based on DG Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.